EUVIMEDEUVIMED entdecken
Crossref

Tumor Immunotherapy Resistance: Underlying Mechanisms and Emerging Strategies to Overcome Therapeutic Bottlenecks

Ziqing Yuan, Chenxi Zhou, Shaoquan Zheng, Jieying Liang

Oncology Communications · 12.08.2026 · 1 (2) · 45-63

DOI: 10.62762/oc.2026.289553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Communications, online erschienen am 12.08.2026. Verfasst von Ziqing Yuan und 3 weiteren Autor:innen. Gefördert von: National Natural Science Foundation of China, GuangDong Basic and Applied Basic Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review presents a systematic synthesis of the principal tumor immunotherapy strategies and their corresponding resistance mechanisms. Immunotherapies—including antibody-based therapies, adoptive cell therapies, immune modulators, and novel approaches such as oncolytic viruses and cancer vaccines—work by stimulating or enhancing the patient's immune system to target cancer cells. Nevertheless, they commonly encounter resistance in clinical applications. Resistance mechanisms predominantly stem from tumor-intrinsic factors and tumor microenvironment (TME) factors. To surmount resistance, combination therapies and personalized treatment strategies grounded in TME profiling and biomarkers represent critical future directions.

Förderung

  • National Natural Science Foundation of China
  • GuangDong Basic and Applied Basic Research Foundation

Zitieren

APA

Yuan, Z., Zhou, C., Zheng, S., & Liang, J. (2026). Tumor Immunotherapy Resistance: Underlying Mechanisms and Emerging Strategies to Overcome Therapeutic Bottlenecks. Oncology Communications, 1(2), 45-63. https://doi.org/10.62762/oc.2026.289553

Vancouver

Yuan Z, Zhou C, Zheng S, Liang J. Tumor Immunotherapy Resistance: Underlying Mechanisms and Emerging Strategies to Overcome Therapeutic Bottlenecks. Oncology Communications. 2026;1(2):45-63. doi:10.62762/oc.2026.289553

BibTeX
@article{Yuan2026,
  author = {Yuan, Ziqing and Zhou, Chenxi and Zheng, Shaoquan and Liang, Jieying},
  title = {Tumor Immunotherapy Resistance: Underlying Mechanisms and Emerging Strategies to Overcome Therapeutic Bottlenecks},
  journal = {Oncology Communications},
  year = {2026},
  volume = {1},
  number = {2},
  pages = {45--63},
  doi = {10.62762/oc.2026.289553}
}
Kostenlos starten →